Alliancebernstein L.P. trimmed its holdings in Chemed Co. (NYSE:CHE - Free Report) by 8.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 19,266 shares of the company's stock after selling 1,771 shares during the quarter. Alliancebernstein L.P. owned approximately 0.13% of Chemed worth $10,207,000 at the end of the most recent quarter.
A number of other large investors have also recently bought and sold shares of the business. CIBC Asset Management Inc increased its stake in shares of Chemed by 5.1% during the 4th quarter. CIBC Asset Management Inc now owns 457 shares of the company's stock worth $242,000 after purchasing an additional 22 shares in the last quarter. CBIZ Investment Advisory Services LLC grew its position in shares of Chemed by 64.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company's stock valued at $30,000 after purchasing an additional 22 shares during the period. CIBC Private Wealth Group LLC increased its stake in Chemed by 13.5% in the fourth quarter. CIBC Private Wealth Group LLC now owns 185 shares of the company's stock valued at $98,000 after purchasing an additional 22 shares during the last quarter. Independent Advisor Alliance boosted its position in shares of Chemed by 1.1% in the fourth quarter. Independent Advisor Alliance now owns 2,279 shares of the company's stock worth $1,207,000 after acquiring an additional 25 shares during the last quarter. Finally, EverSource Wealth Advisors LLC boosted its holdings in shares of Chemed by 7.1% in the 4th quarter. EverSource Wealth Advisors LLC now owns 498 shares of the company's stock valued at $264,000 after purchasing an additional 33 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company's stock.
Analyst Ratings Changes
CHE has been the topic of a number of analyst reports. StockNews.com raised Chemed from a "hold" rating to a "buy" rating in a research report on Friday, March 7th. Royal Bank of Canada lifted their target price on Chemed from $633.00 to $667.00 and gave the stock an "outperform" rating in a report on Friday, March 14th.
View Our Latest Stock Analysis on CHE
Chemed Price Performance
Shares of NYSE CHE traded down $9.42 during mid-day trading on Tuesday, hitting $591.27. The company had a trading volume of 61,888 shares, compared to its average volume of 97,134. Chemed Co. has a 12 month low of $512.12 and a 12 month high of $625.09. The firm has a market cap of $8.64 billion, a P/E ratio of 29.88, a PEG ratio of 2.15 and a beta of 0.49. The business's 50-day simple moving average is $583.92 and its 200-day simple moving average is $567.73.
Chemed Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Monday, February 24th were paid a dividend of $0.50 per share. The ex-dividend date of this dividend was Monday, February 24th. This represents a $2.00 dividend on an annualized basis and a yield of 0.34%. Chemed's payout ratio is 10.05%.
Insiders Place Their Bets
In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the firm's stock in a transaction on Thursday, March 6th. The shares were sold at an average price of $593.67, for a total value of $1,187,340.00. Following the completion of the transaction, the chief executive officer now owns 102,679 shares of the company's stock, valued at approximately $60,957,441.93. This trade represents a 1.91 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 3.32% of the company's stock.
About Chemed
(
Free Report)
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Featured Stories
Before you consider Chemed, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.
While Chemed currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
